Vertex Pharmaceuticals (VRTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX)

VRTX 409.46

-1.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (571)	4/24/2002 10:45:47 AM
From: keokalani'nui	Read Replies (1) of 1169

Market hates the word trend, but maybe is being unfair to this news? The best (approved) anti-IL-1 drug is just OK in RA when judged by composite ACR 20 scores. And if tolerability is truly good as they say at higher doses for 24 weeks, won't you be prescribing the pill first? Other thoughts?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next